Skip to main content

Peer Review reports

From: A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG

Original Submission
12 Dec 2022 Submitted Original manuscript
15 May 2023 Reviewed Reviewer Report
22 May 2023 Reviewed Reviewer Report
21 Jun 2023 Author responded Author comments - Jamilet Miranda
9 Jul 2023 Reviewed Reviewer Report
9 Jul 2023 Reviewed Reviewer Report
11 Aug 2023 Author responded Author comments - Jamilet Miranda
Resubmission - Version 2
21 Jun 2023 Submitted Manuscript version 2
Publishing
23 Aug 2023 Editorially accepted
29 Aug 2023 Article published 10.1186/s12885-023-11330-2

You can find further information about peer review here.

Back to article page